Mecamylamine Hydrochloride

FDA Drug Profile — Vecamyl

Drug Details

Generic Name
Mecamylamine Hydrochloride
Brand Names
Vecamyl
Application Number
ANDA204054
Sponsor
Vyera Pharmaceuticals, LLC
NDC Codes
3
Dosage Forms
TABLET, POWDER
Routes
ORAL
Active Ingredients
MECAMYLAMINE HYDROCHLORIDE

Indications and Usage

INDICATIONS AND USAGE For the management of moderately severe to severe essential hypertension and in uncomplicated cases of malignant hypertension.

Warnings

WARNINGS Mecamylamine, a secondary amine, readily penetrates into the brain and thus may produce central nervous system effects. Tremor, choreiform movements, mental aberrations, and convulsions may occur rarely. These have occurred most often when large doses of Mecamylamine HCl were used, especially in patients with cerebral or renal insufficiency. When ganglion blockers or other potent antihypertensive drugs are discontinued suddenly, hypertensive levels return. In patients with malignant hypertension and others, this may occur abruptly and may cause fatal cerebral vascular accidents or acute congestive heart failure. When Mecamylamine HCl is withdrawn, this should be done gradually and other antihypertensive therapy usually must be substituted. On the other hand, the effects of Mecamylamine HCl sometimes may last from hours to days after therapy is discontinued.